Business Standard

Dr Reddys launches cholesterol drug in US

The drug is a bioequivalent generic version of Pfizer's Lipitor tablets in the US market

Press Trust of India  |  Mumbai 

Pharma major Laboratories today said that it has launched calcium tablets, a bioequivalent generic version of tablets in the US market.

The company has launched calcium tablets in 10 mg, 20 mg, 40 mg and 80 mg, a bioequivalent generic version of tablets in the US market on July 17.

The launch was followed by the approval by the US Food & Administration (USFDA) of ANDA for calcium tablets, a company statement said here.

The brand had US sales of approximately $8.07 billion for the most recent twelve months ending March 2012 according to IMS Health.



calcium tablets are available in bottle count sizes of 90 and 500, the release said.

Last year DRL entered into a settlement agreement with Pfizer to resolve litigation over cholesterol lowering tablets. New York-based Pfizer had sued in 2009.

RECOMMENDED FOR YOU

Dr Reddys launches cholesterol drug in US

The drug is a bioequivalent generic version of Pfizer's Lipitor tablets in the US market

Pharma major Dr Reddy's Laboratories today said that it has launched Atorvastatin calcium tablets, a bioequivalent generic version of Lipitor tablets in the US market.

Pharma major Laboratories today said that it has launched calcium tablets, a bioequivalent generic version of tablets in the US market.

The company has launched calcium tablets in 10 mg, 20 mg, 40 mg and 80 mg, a bioequivalent generic version of tablets in the US market on July 17.

The launch was followed by the approval by the US Food & Administration (USFDA) of ANDA for calcium tablets, a company statement said here.

The brand had US sales of approximately $8.07 billion for the most recent twelve months ending March 2012 according to IMS Health.

calcium tablets are available in bottle count sizes of 90 and 500, the release said.

Last year DRL entered into a settlement agreement with Pfizer to resolve litigation over cholesterol lowering tablets. New York-based Pfizer had sued in 2009.

image
Business Standard
177 22

Dr Reddys launches cholesterol drug in US

The drug is a bioequivalent generic version of Pfizer's Lipitor tablets in the US market

Pharma major Laboratories today said that it has launched calcium tablets, a bioequivalent generic version of tablets in the US market.

The company has launched calcium tablets in 10 mg, 20 mg, 40 mg and 80 mg, a bioequivalent generic version of tablets in the US market on July 17.

The launch was followed by the approval by the US Food & Administration (USFDA) of ANDA for calcium tablets, a company statement said here.

The brand had US sales of approximately $8.07 billion for the most recent twelve months ending March 2012 according to IMS Health.

calcium tablets are available in bottle count sizes of 90 and 500, the release said.

Last year DRL entered into a settlement agreement with Pfizer to resolve litigation over cholesterol lowering tablets. New York-based Pfizer had sued in 2009.

image
Business Standard
177 22